Vast majority of studies has shown a highly increased risk of developing breast cancer in BRCA1 or BRCA2 mutation carriers [4-7] with also a greater incidence of a second contra-lateral tumour [4,5,10]. This evidence concerns the gene BRCA2 and neoplasm.